Group One Trading
PVLA

Group One Trading’s Palvella Therapeutics PVLA Stock Holding History

Group One Trading’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-332
Closed -$34.6K – 9020
2025
Q4 		$34.8K Buy
332
+200
+152% +$17.1K ﹤0.01% 5894
2025
Q3 		$8.28K Hold
132
– – ﹤0.01% 7289
2025
Q2 		$2.98K Sell
132
-180
-58% -$4.22K ﹤0.01% 7281
2025
Q1 		$8.73K Hold
312
– – ﹤0.01% 6351
2024
Q4 		$3.74K Hold
312
– – ﹤0.01% 6535
2024
Q3 		$5.22K Sell
312
-11
-3% -$161 ﹤0.01% 5865
2024
Q2 		$3.19K Buy
323
+2
+0.6% +$23 ﹤0.01% 6112
2024
Q1 		$4.71K Buy
321
+237
+282% +$3.3K ﹤0.01% 6214
2023
Q4 		$1.23K Hold
84
– – ﹤0.01% 6949
2023
Q3 		$2.01K Hold
84
– – ﹤0.01% 7044
2023
Q2 		$1.11K Sell
84
-138
-62% -$8.37K ﹤0.01% 7239
2023
Q1 		$17.3K Buy
222
+63
+40% +$7.29K ﹤0.01% 5603
2022
Q4 		$13.2K Buy
+159
New +$12.8K ﹤0.01% 5872
2022
Q2 		– Sell
-447
Closed -$81.6K – 8664
2022
Q1 		$108K Sell
447
-92
-17% -$24.2K ﹤0.01% 5419
2021
Q4 		$163K Sell
539
-337
-38% -$108K ﹤0.01% 5286
2021
Q3 		$362K Buy
+876
New +$305K ﹤0.01% 4548
2021
Q2 		– Sell
-4
Closed -$877 – 8655
2021
Q1 		$1K Buy
+4
New +$874 ﹤0.01% 7487
2020
Q3 		– Sell
-1
Closed – – 6620
2020
Q2 		$0 Sell
1
-7
-88% -$1.64K ﹤0.01% 6274
2020
Q1 		$2K Hold
8
– – ﹤0.01% 5012
2019
Q4 		$2K Sell
8
-61
-88% -$16.9K ﹤0.01% 4927
2019
Q3 		$19K Buy
69
+59
+590% +$22.8K ﹤0.01% 4366
2019
Q2 		$4K Buy
+10
New +$2.98K ﹤0.01% 4656

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Group One Trading's PVLA Position: Q1 2026 in Review

Group One Trading sold out of Palvella Therapeutics (PVLA) in Q1 2026, closing a stake of 332 shares — an estimated $34.6K sold.

Group One Trading first reported a position in PVLA in Q2 2019 and held it in 22 quarters. The position peaked at $362K in Q3 2021. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Group One Trading reported no remaining Palvella Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 332 Palvella Therapeutics shares in Q1 2026, an estimated $34.6K.
  • Group One Trading first reported a position in Palvella Therapeutics in Q2 2019 and held it in 22 quarters.
  • Group One Trading's Palvella Therapeutics position peaked at $362K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.